Inhibitor Therapeutics, Inc. Proceeds from Notes Payable
Inhibitor Therapeutics, Inc. (INTI) reported Proceeds from Notes Payable of $180.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2024-03-29
- Inhibitor Therapeutics, Inc. proceeds from notes payable for the quarter ending 2022-12-31 was $0.00.
- Inhibitor Therapeutics, Inc. proceeds from notes payable for the quarter ending 2022-09-30 was $80.00K.
- Inhibitor Therapeutics, Inc. proceeds from notes payable for the quarter ending 2022-06-30 was $50.00K, a 33.33% decline year-over-year.
- Inhibitor Therapeutics, Inc. proceeds from notes payable for the quarter ending 2022-03-31 was $50.00K, a 50.50% decline year-over-year.
- Inhibitor Therapeutics, Inc. proceeds from notes payable for fiscal 2022 was $180.00K.
- Inhibitor Therapeutics, Inc. proceeds from notes payable for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Inhibitor Therapeutics, Inc. proceeds from notes payable for fiscal 2020 was $41.60K.
- Inhibitor Therapeutics, Inc. proceeds from notes payable for fiscal 2019 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 6 month as first filed | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 9 month as first filed | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $80.00K derived: sum of 2 quarters · filed 2024-03-29 | $130.00K derived: sum of 3 quarters · filed 2024-03-29 | $180.00K 10-K · filed 2024-03-29 | ||
| 2022-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $130.00K derived: sum of 2 quarters · filed 2022-11-14 | $180.00K 10-Q · filed 2022-11-14 | $4.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2022-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $100.00K 10-Q · filed 2022-08-12 | -$76.00K derived: sum of 3 quarters · filed 2022-08-12 | -$76.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2022-03-31 | $50.00K 10-Q · filed 2022-05-13 | -$126.00K derived: sum of 2 quarters · filed 2022-05-13 | -$126.00K derived: sum of 3 quarters · filed 2022-11-14 | -$51.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-12-31 | -$176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$176.00K derived: sum of 2 quarters · filed 2022-11-14 | -$101.00K derived: sum of 3 quarters · filed 2022-11-14 | $0.00 10-K · filed 2022-03-30 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $75.00K derived: sum of 2 quarters · filed 2022-11-14 | $176.00K 10-Q · filed 2022-11-14 | $0.00 10-Q · filed 2021-11-12 | $176.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $176.00K 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2021-08-13 | $176.00K derived: sum of 3 quarters · filed 2022-08-12 | $176.00K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $101.00K 10-Q · filed 2022-05-13 | $101.00K derived: sum of 2 quarters · filed 2022-05-13 | $101.00K derived: sum of 3 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $41.60K 10-K · filed 2022-03-30 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $41.60K 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | $41.60K 10-Q · filed 2021-08-13 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $0.00 derived: sum of 2 quarters · filed 2021-03-26 | $0.00 10-K · filed 2021-03-26 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-12 |